Opexa Therapeutics is scheduled to present an overview of its T-cell and adult stem cell therapies for autoimmune diseases at an annual health care conference.
Celgene Cellular Therapeutics receives FDA authorization to commence the first clinical trials ever to be conducted in the U.S. with adult stem cells derived from placental blood.
In one of the largest business arrangements ever made, Osiris and Genzyme agree upon a major adult stem cell collaboration.
Researchers in Japan demonstrate that adult stem cells derived from adipose tissue stimulate angiogenesis through the mobilization of endogenous bone marrow stem cells.
Harvest Technologies has received FDA authorization to commence the first clinical trials with autologous adult stem cells in the treatment of critical limb ischemia.
Scientists increase the efficacy of mesenchymal stem cells through a process of molecular “supercharging” for the therapeutic regeneration of heart tissue following myocardial infarction.
Toll Free:
1-800-980-STEM (7836)
Outside or Inside US Call:
1-954-358-3382
Toll Free Fax (US Only):
1-866-755-3951
From Outside US Fax:
1-775-887-1194
Copyright 2025, Stem Cell Insitute Panama. All rights reserved.